GSA CAPITAL PARTNERS LLP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$154,000
+294.9%
486,568
+794.9%
0.02%
+300.0%
Q1 2022$39,000
-94.7%
54,370
-78.6%
0.01%
-93.3%
Q3 2021$733,000
+103.6%
254,376
+97.8%
0.08%
+27.1%
Q4 2020$360,000
+60.0%
128,626
+43.5%
0.06%
+55.3%
Q3 2020$225,000
+118.4%
89,663
+242.4%
0.04%
+171.4%
Q3 2019$103,000
+5.1%
26,187
+140.7%
0.01%
+133.3%
Q1 2016$98,00010,8810.01%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders